(Q35761083)

10 August 2017

title

Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method (English)

1 reference

10 August 2017

Hallander HO

1

1 reference

10 August 2017

Dornbusch K

2

1 reference

10 August 2017

Gezelius L

3

1 reference

10 August 2017

Jacobson K

4

1 reference

10 August 2017

Karlsson I

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 November 1982

1 reference

10 August 2017

number of pages

10

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

743-752

1 reference

Method of reliable determination of minimal lethal antibiotic concentrations

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Methodological variation in antibiotic synergy tests against enterococci

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

In VitroActivity of Cefamandole, Cefoxitin, Cefuroxime, and Carbenicillin, Alone and in Combination with Aminoglycosides againstSerratia marcescens1

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Antimicrobial Synergism--An Elusive Concept

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparison of Techniques for Measurement of in Vitro Antibiotic Synergism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparative in vitro Activity of Cefuroxime and its Interactions with Aminoglycoside Antibiotics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Antibiotic sensitivity testing. Report of an international collaborative study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

A Method for Testing for Synergy with Any Number of Agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

In Vitro Activity of LY127935

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and amino-glycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185655

Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia

25 September 2018

1 reference

12 December 2020

Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum

1 reference

12 December 2020

The assessment of antimicrobial combinations

1 reference

12 December 2020

Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media

1 reference

12 December 2020

Aminoglycosides in the treatment of bacteraemic infections in the immunocompromised host

1 reference

12 December 2020

Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.22.5.743

1 reference

10 August 2017

1 reference

10 August 2017

1 reference